SCHEMBL20910199

SCHEMBL20910199

CC(C)c1ccc2c(CN(C)C)cn(C)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.42
HTR2C P28335 1/20 0.42
HTR2B P41595 1/20 0.42
LMNA P02545 4/20 0.40
MAPT P10636 2/20 0.40
ALDH1A1 P00352 2/20 0.40
SLC6A4 P31645 2/20 0.37
HTR1D P28221 1/20 0.37
HTR1B P28222 1/20 0.37
GPR84 Q9NQS5 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
HTR6 P50406 3/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
HPGD P15428 2/20 0.34
HTT P42858 2/20 0.34
OPRM1 P35372 1/20 0.34
OPRL1 P41146 1/20 0.34
KCNH2 Q12809 1/20 0.34
HTR5A P47898 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23917929 0.83 LMNA (0.45) HTR2ALMNAMAPTALDH1A1GPR84
SCHEMBL27338595 0.80 HTR2A (0.45) HTR2AHTR2CHTR2BLMNAMAPT
SCHEMBL3353333 0.78 HTR6 (0.46) HTR2AHTR2CHTR2BLMNAMAPT
SCHEMBL23604756 0.75 LMNA (0.40) HTR2ALMNAMAPTALDH1A1HTR1D
SCHEMBL13537350 0.75 HTR2A (0.41) HTR2AHTR2CHTR2BLMNAMAPT
SCHEMBL10261961 0.74 GPR84 (0.67) HTR2AHTR2CHTR2BLMNAMAPT
SCHEMBL23393948 0.74 SCN9A (0.36) LMNAMAPTALDH1A1HTR6HTT
SCHEMBL17992597 0.74 IDO1 (0.37) LMNAMAPTALDH1A1HTT
SCHEMBL17660621 0.74 LMNA (0.42) LMNAMAPTALDH1A1SMN1; SMN2HTT
SCHEMBL23490154 0.72 ALDH1A1 (0.43) LMNAMAPTALDH1A1HTR1DSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019074979-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF GIRAFPHARMA, LLC (US) 2019-04-18 WO disclosed